A systematic literature review of surgical interventions for limbal stem cell deficiency in humans
- PMID: 18486098
- DOI: 10.1016/j.ajo.2008.03.018
A systematic literature review of surgical interventions for limbal stem cell deficiency in humans
Abstract
Purpose: To evaluate the relative benefits and to identify any adverse effects of surgical interventions for limbal stem cell deficiency (LSCD).
Design: Systematic literature review.
Methods: We searched the following electronic databases from January 1, 1989 through September 30, 2006: MEDLINE, EMBASE, Science citation index, BIOSIS, and the Cochrane Library. In addition, reference lists were scanned to identify any additional reports. The quality of published reports was assessed using standard methods. The main outcome measure was improvement in vision of at least two Snellen lines of best-corrected visual acuity (BCVA). Data on adverse outcomes also were collected.
Results: Twenty-six studies met the inclusion criteria. There were no randomized controlled studies. All 26 studies were either prospective or retrospective case series. For bilateral severe LSCD, keratolimbal allograft was the most common intervention with systemic immunosuppression. Other interventions included eccentric penetrating keratolimbal allografts and cultivated autologous oral mucosal epithelial grafts. An improvement in BCVA of two lines or more was reported in 31% to 67% of eyes. For unilateral severe LSCD, the most common surgical intervention was contralateral conjunctival limbal autograft, with 35% to 88% of eyes gaining an improvement in BCVA of two lines or more. The only study evaluating partial LSCD showed an improvement in BCVA of two lines or more in 39% of eyes.
Conclusions: Studies to date have not provided strong evidence to guide clinical practice on which surgery is most beneficial to treat various types of LSCD. Standardized data collection in a multicenter LSCD register is suggested.
Comment in
-
Surgical treatment of limbal stem cell deficiency: are we really transplanting stem cells?Am J Ophthalmol. 2008 Aug;146(2):154-5. doi: 10.1016/j.ajo.2008.04.025. Am J Ophthalmol. 2008. PMID: 18656582 No abstract available.
Similar articles
-
Outcomes of surgical interventions for the treatment of limbal stem cell deficiency.Indian J Med Res. 2021 Jul;154(1):51-61. doi: 10.4103/ijmr.IJMR_1139_18. Indian J Med Res. 2021. PMID: 34782530 Free PMC article.
-
Blue-light filtering intraocular lenses (IOLs) for protecting macular health.Cochrane Database Syst Rev. 2018 May 22;5(5):CD011977. doi: 10.1002/14651858.CD011977.pub2. Cochrane Database Syst Rev. 2018. PMID: 29786830 Free PMC article.
-
Systematic review and meta-analysis on transplantation of ex vivo cultivated limbal epithelial stem cell on amniotic membrane in limbal stem cell deficiency.Cornea. 2015 May;34(5):592-600. doi: 10.1097/ICO.0000000000000398. Cornea. 2015. PMID: 25789694
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
Surgery for cataracts in people with age-related macular degeneration.Cochrane Database Syst Rev. 2017 Feb 16;2(2):CD006757. doi: 10.1002/14651858.CD006757.pub4. Cochrane Database Syst Rev. 2017. PMID: 28206671 Free PMC article.
Cited by
-
Effects of preservation time on proliferative potential of human limbal stem/progenitor cells.Int J Ophthalmol. 2012;5(5):549-54. doi: 10.3980/j.issn.2222-3959.2012.05.02. Epub 2012 Oct 18. Int J Ophthalmol. 2012. PMID: 23166863 Free PMC article.
-
Systematic review and Meta-analysis comparing modified cross-linking and standard cross-linking for progressive keratoconus.Int J Ophthalmol. 2017 Sep 18;10(9):1419-1429. doi: 10.18240/ijo.2017.09.15. eCollection 2017. Int J Ophthalmol. 2017. PMID: 28944203 Free PMC article.
-
Corneal neovascularization and the utility of topical VEGF inhibition: ranibizumab (Lucentis) vs bevacizumab (Avastin).Ocul Surf. 2012 Apr;10(2):67-83. doi: 10.1016/j.jtos.2012.01.005. Epub 2012 Jan 25. Ocul Surf. 2012. PMID: 22482468 Free PMC article. Review.
-
Limbal stem cell transplantation: current perspectives.Clin Ophthalmol. 2016 Apr 1;10:593-602. doi: 10.2147/OPTH.S83676. eCollection 2016. Clin Ophthalmol. 2016. PMID: 27099468 Free PMC article. Review.
-
Xenofree generation of limbal stem cells for ocular surface advanced cell therapy.Stem Cell Res Ther. 2019 Dec 4;10(1):374. doi: 10.1186/s13287-019-1501-9. Stem Cell Res Ther. 2019. PMID: 31801638 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous